{
  "DOI": "10.1038/ejhg.2009.45",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/ejhg.2009.45",
  "alternative-id": [
    "BFejhg200945"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Zhang",
      "given": "Zhizhong",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Qiu",
      "given": "Lixin",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wang",
      "given": "Meilin",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Tong",
      "given": "Na",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Li",
      "given": "Jin",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zhang",
      "given": "Zhengdong",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2009,
        4,
        1
      ]
    ],
    "date-time": "2009-04-01T10:28:50Z",
    "timestamp": 1238581730000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        24
      ]
    ],
    "date-time": "2023-05-24T18:19:56Z",
    "timestamp": 1684952396000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        2,
        13
      ]
    ],
    "date-time": "2024-02-13T01:05:49Z",
    "timestamp": 1707786349886
  },
  "is-referenced-by-count": 24,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "10",
  "issued": {
    "date-parts": [
      [
        2009,
        4,
        1
      ]
    ]
  },
  "journal-issue": {
    "issue": "10",
    "published-print": {
      "date-parts": [
        [
          2009,
          10
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2009,
            4,
            1
          ]
        ],
        "date-time": "2009-04-01T00:00:00Z",
        "timestamp": 1238544000000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/ejhg200945.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg200945",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg200945.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1294-1303",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2009,
        4,
        1
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2009,
        4,
        1
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2009,
        10
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1034/j.1600-065X.2003.00051.x",
      "author": "DR Green",
      "doi-asserted-by": "publisher",
      "first-page": "70",
      "journal-title": "Immunol Rev",
      "key": "BFejhg200945_CR1",
      "unstructured": "Green DR, Droin N, Pinkoski M : Activation-induced cell death in T cells. Immunol Rev 2003; 193: 70–81.",
      "volume": "193",
      "year": "2003"
    },
    {
      "DOI": "10.1046/j.1440-1711.2002.01068.x",
      "author": "S Maher",
      "doi-asserted-by": "publisher",
      "first-page": "131",
      "journal-title": "Immunol Cell Biol",
      "key": "BFejhg200945_CR2",
      "unstructured": "Maher S, Toomey D, Condron C, Bouchier-Hayes D : Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumour counterattack. Immunol Cell Biol 2002; 80: 131–137.",
      "volume": "80",
      "year": "2002"
    },
    {
      "DOI": "10.1007/s002620050505",
      "author": "DB Chappell",
      "doi-asserted-by": "publisher",
      "first-page": "65",
      "journal-title": "Cancer Immunol Immunother",
      "key": "BFejhg200945_CR3",
      "unstructured": "Chappell DB, Restifo NP : T cell-tumor cell: a fatal interaction? Cancer Immunol Immunother 1998; 47: 65–71.",
      "volume": "47",
      "year": "1998"
    },
    {
      "DOI": "10.1038/373444a0",
      "author": "ST Ju",
      "doi-asserted-by": "publisher",
      "first-page": "444",
      "journal-title": "Nature",
      "key": "BFejhg200945_CR4",
      "unstructured": "Ju ST, Panka DJ, Cui H et al: Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995; 373: 444–448.",
      "volume": "373",
      "year": "1995"
    },
    {
      "DOI": "10.1126/science.270.5239.1189",
      "author": "TS Griffith",
      "doi-asserted-by": "publisher",
      "first-page": "1189",
      "journal-title": "Science",
      "key": "BFejhg200945_CR5",
      "unstructured": "Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA : Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270: 1189–1192.",
      "volume": "270",
      "year": "1995"
    },
    {
      "DOI": "10.1084/jem.184.3.1075",
      "author": "J O’Connell",
      "doi-asserted-by": "publisher",
      "first-page": "1075",
      "journal-title": "J Exp Med",
      "key": "BFejhg200945_CR6",
      "unstructured": "O’Connell J, O’Sullivan GC, Collins JK, Shanahan F : The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med 1996; 184: 1075–1082.",
      "volume": "184",
      "year": "1996"
    },
    {
      "DOI": "10.1038/sj.onc.1204935",
      "author": "T Crnogorac-Jurcevic",
      "doi-asserted-by": "publisher",
      "first-page": "7437",
      "journal-title": "Oncogene",
      "key": "BFejhg200945_CR7",
      "unstructured": "Crnogorac-Jurcevic T, Efthimiou E, Capelli P et al: Gene expression profiles of pancreatic cancer and stromal desmoplasia. Oncogene 2001; 20: 7437–7446.",
      "volume": "20",
      "year": "2001"
    },
    {
      "author": "GA Niehans",
      "first-page": "1007",
      "journal-title": "Cancer Res",
      "key": "BFejhg200945_CR8",
      "unstructured": "Niehans GA, Brunner T, Frizelle SP et al: Human lung carcinomas express Fas ligand. Cancer Res 1997; 57: 1007–1012.",
      "volume": "57",
      "year": "1997"
    },
    {
      "DOI": "10.4049/jimmunol.160.11.5669",
      "author": "MW Bennett",
      "doi-asserted-by": "crossref",
      "first-page": "5669",
      "journal-title": "J Immunol",
      "key": "BFejhg200945_CR9",
      "unstructured": "Bennett MW, O’Connell J, O’Sullivan GC et al: The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma. J Immunol 1998; 160: 5669–5675.",
      "volume": "160",
      "year": "1998"
    },
    {
      "DOI": "10.1016/j.coph.2004.03.008",
      "author": "A Houston",
      "doi-asserted-by": "publisher",
      "first-page": "321",
      "journal-title": "Curr Opin Pharmacol",
      "key": "BFejhg200945_CR10",
      "unstructured": "Houston A, O’Connell J : The Fas signalling pathway and its role in the pathogenesis of cancer. Curr Opin Pharmacol 2004; 4: 321–326.",
      "volume": "4",
      "year": "2004"
    },
    {
      "DOI": "10.4049/jimmunol.170.1.132",
      "author": "J Wu",
      "doi-asserted-by": "publisher",
      "first-page": "132",
      "journal-title": "J Immunol",
      "key": "BFejhg200945_CR11",
      "unstructured": "Wu J, Metz C, Xu X et al: A novel polymorphic CAAT/enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients. J Immunol 2003; 170: 132–138.",
      "volume": "170",
      "year": "2003"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-05-1739",
      "author": "Z Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "5596",
      "journal-title": "Clin Cancer Res",
      "key": "BFejhg200945_CR12",
      "unstructured": "Zhang Z, Wang LE, Sturgis EM et al: Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck. Clin Cancer Res 2006; 12: 5596–5602.",
      "volume": "12",
      "year": "2006"
    },
    {
      "DOI": "10.1093/carcin/bgm211",
      "author": "KD Crew",
      "doi-asserted-by": "publisher",
      "first-page": "2548",
      "journal-title": "Carcinogenesis",
      "key": "BFejhg200945_CR13",
      "unstructured": "Crew KD, Gammon MD, Terry MB et al: Genetic polymorphisms in the apoptosis-associated genes FAS and FASL and breast cancer risk. Carcinogenesis 2007; 28: 2548–2551.",
      "volume": "28",
      "year": "2007"
    },
    {
      "DOI": "10.1093/jnci/djh289",
      "author": "P Krippl",
      "doi-asserted-by": "publisher",
      "first-page": "1478",
      "journal-title": "J Natl Cancer Inst",
      "key": "BFejhg200945_CR14",
      "unstructured": "Krippl P, Langsenlehner U, Renner W, Koppel H, Samonigg H : Re: Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma. J Natl Cancer Inst 2004; 96: 1478–1479; author reply 1479.",
      "volume": "96",
      "year": "2004"
    },
    {
      "DOI": "10.1093/carcin/bgl250",
      "author": "B Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "1067",
      "journal-title": "Carcinogenesis",
      "key": "BFejhg200945_CR15",
      "unstructured": "Zhang B, Sun T, Xue L et al: Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer. Carcinogenesis 2007; 28: 1067–1073.",
      "volume": "28",
      "year": "2007"
    },
    {
      "DOI": "10.1084/jem.20050707",
      "author": "T Sun",
      "doi-asserted-by": "publisher",
      "first-page": "967",
      "journal-title": "J Exp Med",
      "key": "BFejhg200945_CR16",
      "unstructured": "Sun T, Zhou Y, Li H et al: FASL −844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer. J Exp Med 2005; 202: 967–974.",
      "volume": "202",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.ygyno.2005.05.010",
      "author": "HC Lai",
      "doi-asserted-by": "publisher",
      "first-page": "113",
      "journal-title": "Gynecol Oncol",
      "key": "BFejhg200945_CR17",
      "unstructured": "Lai HC, Lin WY, Lin YW et al: Genetic polymorphisms of FAS and FASL (CD95/CD95L) genes in cervical carcinogenesis: an analysis of haplotype and gene-gene interaction. Gynecol Oncol 2005; 99: 113–118.",
      "volume": "99",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.cancergencyto.2007.09.002",
      "author": "S Kang",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Cancer Genet Cytogenet",
      "key": "BFejhg200945_CR18",
      "unstructured": "Kang S, Dong SM, Seo SS, Kim JW, Park SY : FAS −1377 G/A polymorphism and the risk of lymph node metastasis in cervical cancer. Cancer Genet Cytogenet 2008; 180: 1–5.",
      "volume": "180",
      "year": "2008"
    },
    {
      "DOI": "10.1002/ijc.22989",
      "author": "EL Ivansson",
      "doi-asserted-by": "publisher",
      "first-page": "2451",
      "journal-title": "Int J Cancer",
      "key": "BFejhg200945_CR19",
      "unstructured": "Ivansson EL, Gustavsson IM, Magnusson JJ et al: Variants of chemokine receptor 2 and interleukin 4 receptor, but not interleukin 10 or Fas ligand, increase risk of cervical cancer. Int J Cancer 2007; 121: 2451–2457.",
      "volume": "121",
      "year": "2007"
    },
    {
      "DOI": "10.1097/01.fpc.0000194425.58511.a7",
      "author": "C Li",
      "doi-asserted-by": "publisher",
      "first-page": "245",
      "journal-title": "Pharmacogenet Genomics",
      "key": "BFejhg200945_CR20",
      "unstructured": "Li C, Wu W, Liu J et al: Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis. Pharmacogenet Genomics 2006; 16: 245–251.",
      "volume": "16",
      "year": "2006"
    },
    {
      "DOI": "10.1136/jmg.2004.030106",
      "author": "X Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "479",
      "journal-title": "J Med Genet",
      "key": "BFejhg200945_CR21",
      "unstructured": "Zhang X, Miao X, Sun T et al: Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer. J Med Genet 2005; 42: 479–484.",
      "volume": "42",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.lungcan.2006.09.002",
      "author": "SH Park",
      "doi-asserted-by": "publisher",
      "first-page": "303",
      "journal-title": "Lung Cancer",
      "key": "BFejhg200945_CR22",
      "unstructured": "Park SH, Choi JE, Kim EJ et al: Polymorphisms in the FAS and FASL genes and risk of lung cancer in a Korean population. Lung Cancer 2006; 54: 303–308.",
      "volume": "54",
      "year": "2006"
    },
    {
      "DOI": "10.1093/carcin/bgn205",
      "author": "M Ter-Minassian",
      "doi-asserted-by": "publisher",
      "first-page": "2147",
      "journal-title": "Carcinogenesis",
      "key": "BFejhg200945_CR23",
      "unstructured": "Ter-Minassian M, Zhai R, Asomaning K et al: Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer. Carcinogenesis 2008; 29: 2147–2152.",
      "volume": "29",
      "year": "2008"
    },
    {
      "DOI": "10.1097/PPO.0b013e318046f214",
      "author": "H Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "233",
      "journal-title": "Cancer J",
      "key": "BFejhg200945_CR24",
      "unstructured": "Zhang H, Sun XF, Synnerstad I, Rosdahl I : Importance of FAS-1377, FAS-670, and FASL-844 polymorphisms in tumor onset, progression, and pigment phenotypes of Swedish patients with melanoma: a case-control analysis. Cancer J 2007; 13: 233–237.",
      "volume": "13",
      "year": "2007"
    },
    {
      "DOI": "10.1097/01.fpc.0000199501.54466.de",
      "author": "C Li",
      "doi-asserted-by": "publisher",
      "first-page": "253",
      "journal-title": "Pharmacogenet Genomics",
      "key": "BFejhg200945_CR25",
      "unstructured": "Li C, Larson D, Zhang Z et al: Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma. Pharmacogenet Genomics 2006; 16: 253–263.",
      "volume": "16",
      "year": "2006"
    },
    {
      "DOI": "10.1093/jnci/djh187",
      "author": "T Sun",
      "doi-asserted-by": "publisher",
      "first-page": "1030",
      "journal-title": "J Natl Cancer Inst",
      "key": "BFejhg200945_CR26",
      "unstructured": "Sun T, Miao X, Zhang X, Tan W, Xiong P, Lin D : Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma. J Natl Cancer Inst 2004; 96: 1030–1036.",
      "volume": "96",
      "year": "2004"
    },
    {
      "author": "PI Hsu",
      "first-page": "97",
      "journal-title": "Anticancer Res",
      "key": "BFejhg200945_CR27",
      "unstructured": "Hsu PI, Lu PJ, Wang EM et al: Polymorphisms of death pathway genes FAS and FASL and risk of premalignant gastric lesions. Anticancer Res 2008; 28: 97–103.",
      "volume": "28",
      "year": "2008"
    },
    {
      "author": "U Gormus",
      "first-page": "991",
      "journal-title": "Anticancer Res",
      "key": "BFejhg200945_CR28",
      "unstructured": "Gormus U, Ergen A, Yilmaz H, Dalan B, Berkman S, Isbir T : Fas-1377A/G and FasL-844 T/C gene polymorphisms and epithelial ovarian cancer. Anticancer Res 2007; 27: 991–994.",
      "volume": "27",
      "year": "2007"
    },
    {
      "DOI": "10.1007/BF03346319",
      "author": "M Erdogan",
      "doi-asserted-by": "publisher",
      "first-page": "411",
      "journal-title": "J Endocrinol Invest",
      "key": "BFejhg200945_CR29",
      "unstructured": "Erdogan M, Karadeniz M, Berdeli A et al: Fas/Fas ligand gene polymorphism in patients with papillary thyroid cancer in the Turkish population. J Endocrinol Invest 2007; 30: 411–416.",
      "volume": "30",
      "year": "2007"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-08-0177",
      "author": "M Yang",
      "doi-asserted-by": "publisher",
      "first-page": "3230",
      "journal-title": "Clin Cancer Res",
      "key": "BFejhg200945_CR30",
      "unstructured": "Yang M, Sun T, Wang L et al: Functional variants in cell death pathway genes and risk of pancreatic cancer. Clin Cancer Res 2008; 14: 3230–3236.",
      "volume": "14",
      "year": "2008"
    },
    {
      "DOI": "10.2188/jea.15.S157",
      "author": "D Qiu",
      "doi-asserted-by": "publisher",
      "first-page": "S157",
      "issue": "Suppl 2",
      "journal-title": "J Epidemiol",
      "key": "BFejhg200945_CR31",
      "unstructured": "Qiu D, Kurosawa M, Lin Y et al: Overview of the epidemiology of pancreatic cancer focusing on the JACC Study. J Epidemiol 2005; 15 (Suppl 2): S157–S167.",
      "volume": "15",
      "year": "2005"
    },
    {
      "DOI": "10.1093/jnci/92.6.440",
      "author": "Q Wei",
      "doi-asserted-by": "publisher",
      "first-page": "1764",
      "journal-title": "J Natl Cancer Inst",
      "key": "BFejhg200945_CR32",
      "unstructured": "Wei Q, Cheng L, Amos CI et al: Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst 2000; 92: 1764–1772.",
      "volume": "92",
      "year": "2000"
    },
    {
      "DOI": "10.1080/00365590050509869",
      "author": "SM Cohen",
      "doi-asserted-by": "publisher",
      "first-page": "105",
      "journal-title": "Scand J Urol Nephrol Suppl",
      "key": "BFejhg200945_CR33",
      "unstructured": "Cohen SM, Shirai T, Steineck G : Epidemiology and etiology of premalignant and malignant urothelial changes. Scand J Urol Nephrol Suppl 2000; 205: 105–115.",
      "volume": "205",
      "year": "2000"
    },
    {
      "author": "WJ Blot",
      "first-page": "3282",
      "journal-title": "Cancer Res",
      "key": "BFejhg200945_CR34",
      "unstructured": "Blot WJ, McLaughlin JK, Winn DM et al: Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988; 48: 3282–3287.",
      "volume": "48",
      "year": "1988"
    },
    {
      "DOI": "10.1016/j.ijheh.2006.10.003",
      "author": "WW Au",
      "doi-asserted-by": "publisher",
      "first-page": "671",
      "journal-title": "Int J Hyg Environ Health",
      "key": "BFejhg200945_CR35",
      "unstructured": "Au WW, Abdou-Salama S, Sierra-Torres CH, Al-Hendy A : Environmental risk factors for prevention and molecular intervention of cervical cancer. Int J Hyg Environ Health 2007; 210: 671–678.",
      "volume": "210",
      "year": "2007"
    },
    {
      "DOI": "10.1016/S0960-0760(00)00113-8",
      "author": "I Persson",
      "doi-asserted-by": "publisher",
      "first-page": "357",
      "journal-title": "J Steroid Biochem Mol Biol",
      "key": "BFejhg200945_CR36",
      "unstructured": "Persson I : Estrogens in the causation of breast, endometrial and ovarian cancers – evidence and hypotheses from epidemiological findings. J Steroid Biochem Mol Biol 2000; 74: 357–364.",
      "volume": "74",
      "year": "2000"
    },
    {
      "author": "N Mantel",
      "first-page": "719",
      "journal-title": "J Natl Cancer Inst",
      "key": "BFejhg200945_CR37",
      "unstructured": "Mantel N, Haenszel W : Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719–748.",
      "volume": "22",
      "year": "1959"
    },
    {
      "DOI": "10.1016/0197-2456(86)90046-2",
      "author": "R DerSimonian",
      "doi-asserted-by": "publisher",
      "first-page": "177",
      "journal-title": "Control Clin Trials",
      "key": "BFejhg200945_CR38",
      "unstructured": "DerSimonian R, Laird N : Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177–188.",
      "volume": "7",
      "year": "1986"
    },
    {
      "DOI": "10.1002/sim.4780101105",
      "author": "A Whitehead",
      "doi-asserted-by": "publisher",
      "first-page": "1665",
      "journal-title": "Stat Med",
      "key": "BFejhg200945_CR39",
      "unstructured": "Whitehead A, Whitehead J : A general parametric approach to the meta-analysis of randomized clinical trials. Stat Med 1991; 10: 1665–1677.",
      "volume": "10",
      "year": "1991"
    },
    {
      "DOI": "10.1136/bmj.315.7109.629",
      "author": "M Egger",
      "doi-asserted-by": "publisher",
      "first-page": "629",
      "journal-title": "BMJ",
      "key": "BFejhg200945_CR40",
      "unstructured": "Egger M, Davey Smith G, Schneider M, Minder C : Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629–634.",
      "volume": "315",
      "year": "1997"
    },
    {
      "DOI": "10.1002/sim.2010",
      "author": "A Thakkinstian",
      "doi-asserted-by": "publisher",
      "first-page": "1291",
      "journal-title": "Stat Med",
      "key": "BFejhg200945_CR41",
      "unstructured": "Thakkinstian A, McElduff P, D’Este C, Duffy D, Attia J : A method for meta-analysis of molecular association studies. Stat Med 2005; 24: 1291–1306.",
      "volume": "24",
      "year": "2005"
    },
    {
      "DOI": "10.1016/0167-5699(93)90231-9",
      "author": "D Kabelitz",
      "doi-asserted-by": "publisher",
      "first-page": "338",
      "journal-title": "Immunol Today",
      "key": "BFejhg200945_CR42",
      "unstructured": "Kabelitz D, Pohl T, Pechhold K : Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol Today 1993; 14: 338–339.",
      "volume": "14",
      "year": "1993"
    },
    {
      "DOI": "10.1289/ehp.02110s1119",
      "author": "LS DeBruin",
      "doi-asserted-by": "publisher",
      "first-page": "119",
      "issue": "Suppl 1",
      "journal-title": "Environ Health Perspect",
      "key": "BFejhg200945_CR43",
      "unstructured": "DeBruin LS, Josephy PD : Perspectives on the chemical etiology of breast cancer. Environ Health Perspect 2002; 110 (Suppl 1): 119–128.",
      "volume": "110",
      "year": "2002"
    },
    {
      "DOI": "10.1006/cimm.1998.1432",
      "author": "N Suzuki",
      "doi-asserted-by": "publisher",
      "first-page": "48",
      "journal-title": "Cell Immunol",
      "key": "BFejhg200945_CR44",
      "unstructured": "Suzuki N, Wakisaka S, Takeba Y, Mihara S, Sakane T : Effects of cigarette smoking on Fas/Fas ligand expression of human lymphocytes. Cell Immunol 1999; 192: 48–53.",
      "volume": "192",
      "year": "1999"
    },
    {
      "author": "A Elnemr",
      "first-page": "33",
      "journal-title": "Int J Oncol",
      "key": "BFejhg200945_CR45",
      "unstructured": "Elnemr A, Ohta T, Yachie A et al: Human pancreatic cancer cells express non-functional Fas receptors and counterattack lymphocytes by expressing Fas ligand; a potential mechanism for immune escape. Int J Oncol 2001; 18: 33–39.",
      "volume": "18",
      "year": "2001"
    },
    {
      "DOI": "10.3322/canjclin.41.3.146",
      "author": "JL Kelsey",
      "doi-asserted-by": "publisher",
      "first-page": "146",
      "journal-title": "CA Cancer J Clin",
      "key": "BFejhg200945_CR46",
      "unstructured": "Kelsey JL, Gammon MD : The epidemiology of breast cancer. CA Cancer J Clin 1991; 41: 146–165.",
      "volume": "41",
      "year": "1991"
    },
    {
      "DOI": "10.1023/A:1021649019025",
      "author": "RX Song",
      "doi-asserted-by": "publisher",
      "first-page": "55",
      "journal-title": "Apoptosis",
      "key": "BFejhg200945_CR47",
      "unstructured": "Song RX, Santen RJ : Apoptotic action of estrogen. Apoptosis 2003; 8: 55–60.",
      "volume": "8",
      "year": "2003"
    },
    {
      "DOI": "10.1111/j.1749-6632.2001.tb03811.x",
      "author": "A Akhmedkhanov",
      "doi-asserted-by": "publisher",
      "first-page": "296",
      "journal-title": "Ann NY Acad Sci",
      "key": "BFejhg200945_CR48",
      "unstructured": "Akhmedkhanov A, Zeleniuch-Jacquotte A, Toniolo P : Role of exogenous and endogenous hormones in endometrial cancer: review of the evidence and research perspectives. Ann NY Acad Sci 2001; 943: 296–315.",
      "volume": "943",
      "year": "2001"
    },
    {
      "DOI": "10.1016/S0960-0760(00)00081-9",
      "author": "G Mor",
      "doi-asserted-by": "publisher",
      "first-page": "185",
      "journal-title": "J Steroid Biochem Mol Biol",
      "key": "BFejhg200945_CR49",
      "unstructured": "Mor G, Kohen F, Garcia-Velasco J et al: Regulation of fas ligand expression in breast cancer cells by estrogen: functional differences between estradiol and tamoxifen. J Steroid Biochem Mol Biol 2000; 73: 185–194.",
      "volume": "73",
      "year": "2000"
    },
    {
      "DOI": "10.1074/jbc.274.45.32099",
      "author": "L Dong",
      "doi-asserted-by": "publisher",
      "first-page": "32099",
      "journal-title": "J Biol Chem",
      "key": "BFejhg200945_CR50",
      "unstructured": "Dong L, Wang W, Wang F et al: Mechanisms of transcriptional activation of bcl-2 gene expression by 17beta-estradiol in breast cancer cells. J Biol Chem 1999; 274: 32099–32107.",
      "volume": "274",
      "year": "1999"
    }
  ],
  "reference-count": 50,
  "references-count": 50,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/ejhg200945"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "The FAS ligand promoter polymorphism, rs763110 (−844C\u0026gt;T), contributes to cancer susceptibility: evidence from 19 case–control studies"
  ],
  "type": "journal-article",
  "volume": "17"
}